Dr. Grothey on Potential Combinations With Trastuzumab Deruxtecan in GI Malignancies | OncLive
Dr. Grothey on Potential Combinations With Trastuzumab …
Feb 11, 2021
onclive.com
Dr. Garon on the Efficacy of Datopotamab Deruxtecan in NSCLC
Dr. Garon on the Efficacy of Datopotamab Deruxtecan in NSCLC
Sep 11, 2021
onclive.com
ASCO® 2024 Insights: "I-SPY2.2 Trial - Pathologic Response to Neoadjuvant Datopotamab Deruxtecan in Breast Cancer"
ASCO® 2024 Insights: "I-SPY2.2 Trial - Pathologic Response to Ne…
251 viewsJun 20, 2024
vumedi.com
3.2K views · 13 reactions | Exciting new data from TROPION-Breast02 showed that datopotamab deruxtecan (Dato-DXd) resulted in an unprecedented median overall survival of 5 months vs chemotherapy. We spoke with Rebecca Dent, MD, about what #pharmacists need to know. #breastcancer #esmo25 | Pharmacy Times | Facebook
0:51
3.2K views · 13 reactions | Exciting new data from TROPION-Breast02 …
2K views1 month ago
FacebookPharmacy Times
Dr. Levy on the Efficacy of Datopotamab Deruxtecan Plus Pembrolizumab in NSCLC | OncLive
Dr. Levy on the Efficacy of Datopotamab Deruxtecan Plus Pe…
Aug 9, 2022
onclive.com
FDA Approves New ADC for Lung Cancer Treatment
FDA Approves New ADC for Lung Cancer Treatment
6 months ago
medscape.com
TROPION-Lung01 & TROPION-Lung05: datopotamab deruxtecan for NSCLC
TROPION-Lung01 & TROPION-Lung05: datopotamab deruxtecan …
Nov 27, 2024
vjoncology.com
6:32
The TROPION-Breast01 Trial: Datopotamab Deruxtecan in HR+, …
1 week ago
onclive.com
11:55
Datopotamab Deruxtecan (Dato-DXd) in Patients With Previously T…
1 week ago
onclive.com
9:52
Intracranial Efficacy of Datopotamab Deruxtecan in Patients With Previ…
1 week ago
onclive.com
11:11
Datopotamab Deruxtecan (Dato-DXd) vs Chemotherapy for Patient…
Oct 30, 2023
onclive.com
Trastuzumab Deruxtecan (T-DXd) in HER2 mCRC | OncLive
Apr 25, 2024
onclive.com
Trastuzumab Deruxtecan Shows Clinical Activity in HER2 Solid Tu…
Aug 7, 2023
targetedonc.com
FDA Approves First Targeted Drug To Treat HER2-Low Breast Cancer…
Aug 5, 2022
mskcc.org
Dr Johnson on the Initial Efficacy of Ifinatamab Deruxtecan in Refracto…
Sep 18, 2023
onclive.com
2:49
Patritumab Deruxtecan (HER3-DXd) in Patients with EGFR Mutation-Po…
Feb 9, 2024
onclive.com
Trastuzumab Deruxtecan for Patients With HER2+ Metastatic Br…
4 weeks ago
onclive.com
Patritumab Deruxtecan (HER3-DXd) in EGFR-Mutated NSCLC Followin…
1 week ago
onclive.com
Dr. Iyengar on the Benefit of Trastuzumab Deruxtecan in Metas…
Jan 24, 2023
onclive.com
7:05
TROPION-Breast02: first-line datopotamab deruxtecan in metas…
2 views1 month ago
YouTubeVJOncology
Trastuzumab deruxtecan: a promising agent for treating HER…
1.7K viewsMay 5, 2021
YouTubeVJOncology
Trastuzumab Deruxtecan for HER2+ Breast Cancer
8.4K viewsMar 27, 2018
YouTubeOncLive
5:40
Trastuzumab deruxtecan doubles PFS in metastatic breast cancer wi…
821 viewsJun 15, 2022
YouTubeecancer
5:26
Trastuzumab deruxtecan shows benefit in patients with HER2 + mBC
816 viewsMay 17, 2023
YouTubeecancer
8:42
Trastuzumab Deruxtecan in HER2+ Breast Cancer
503 viewsJul 7, 2020
YouTubeTargeted Oncology
11:42
The Future of Medicine
319K viewsOct 12, 2017
YouTubeCambridge University
1:43
Monoclonal Antibodies: Making Cancer a Target
115.2K viewsJul 6, 2015
YouTubeCancer Research Institute
5:05
Anti-HER2 Mechanisms of Approved HER2 Inhibitors
162.9K viewsApr 30, 2013
YouTubeHMP Education
2:21
Osimertinib in Advanced Non–Small-Cell Lung Cancer
46.4K viewsFeb 16, 2017
YouTubeNEJM Group
3:50
Herceptin (trastuzumab) for HER2-Positive Breast and Stomach Cancer
44.6K viewsOct 21, 2015
YouTubeOncology Associates
See more videos
Static thumbnail place holder